[1] [1] DASSNER A M, NICOLAU D P, GIROTTO J E. Management of pneumonia in the pediatric critical care unit: an area for antimicrobial stewardship ［J］. Current Pediatric Reviews, 2017, 13(1): 49-66.

[2] [2] JAIN S, WILLIAMS D J, ARNOLD S R, et al. Community-acquired pneumonia requiring hospitalization among U.S. children ［J］. The New England Journal of Medicine, 2015, 372(9): 835-845.

[3] [3] YUN K W, WALLIHAN R, JUERGENSEN A, et al. Community-acquired pneumonia in children: myths and facts ［J］. American Journal of Perinatology, 2019, 36(suppl S2): S54-S57.

[4] [4] QI X, SUN X, LI X, et al. Significance changes in the levels of myocardial enzyme in the child patients with mycoplasma pneumoniae pneumonia ［J］. Cellular and Molecular Biology (Noisy-le-Grand, France), 2020, 66(6): 41-45.

[5] [5] ZHOU L P, CHEN X Y, YUAN B. Changes of myocardial enzymes in children with acute mycoplasma pneumonia infection and analysis of related factors ［J］. Journal of Clinical Pulmonary Medicine, 2018, 23(10): 1799-1803.

[6] [6] DENG M H, LIN C W, SUN Y N, et al. Role of E-selectin for diagnosing myocardial injury in pediatric patients with mycoplasma pneumoniae pneumonia ［J］. Annals of Clinical Biochemistry, 2017, 54(1): 49-54.

[7] [7] LI C M, GU L, YIN S J, et al. Age-specific mycoplasma pneumoniae pneumonia-associated myocardial damage in children ［J］. The Journal of International Medical Research, 2013, 41(5): 1716-1723.

[8] [8] GUO L, LIU F, LU M P, et al. Increased T cell activation in BALF from children with Mycoplasma pneumoniae pneumonia ［J］. Pediatric Pulmonology, 2015, 50(8): 814-819.

[9] [9] TENG X, WANG Y, LIN N, et al. Evaluation of serum procalcitonin and C-reactive protein levels as biomarkers of Henoch-Sch?nlein purpura in pediatric patients ［J］. Pediatric Pulmonology, 2016, 35(3): 667-671.

[10] [10] YU Y, LI X X, JIANG L X, et al. Procalcitonin levels in patients with positive blood culture, positive body fluid culture, sepsis, and severe sepsis: a cross-sectional study ［J］. Infectious Diseases, 2016, 48(1): 63-69.

[11] [11] CHENG S, LIN J. Development and validation of a simple-to-use nomogram for predicting refractory mycoplasma pneumoniae pneumonia in children ［J］. Pediatric Pulmonology, 2020, 55(4): 968-974.

[12] [12] ANDERSON R, NEL J G, FELDMAN C. Multifaceted role of pneumolysin in the pathogenesis of myocardial injury in community-acquired pneumonia ［J］. International Journal of Molecular Sciences, 2018, 19(4): 1-22.

[13] [13] RANSTAM J, COOK J A, COLLINS G S. Clinical prediction models ［J］. The British Journal of Surgery, 2016, 103(13): 1886.

[14] [14] ZHOU B, TIAN R. Mitochondrial dysfunction in pathophysiology of heart failure ［J］. The Journal of Clinical Investigation, 2018, 128(9): 3716-3726.

[15] [15] NITZAN M, NITZAN I, ARIELI Y. The various oximetric techniques used for the evaluation of blood oxygenation ［J］. Sensors (Basel, Switzerland), 2020, 20(17): 11-15.

[16] [16] JIN J K, BLACKWOOD E A, AZIZI K, et al. ATF6 decreases myocardial ischemia/reperfusion damage and links ER stress and oxidative stress signaling pathways in the heart ［J］. Circulation Research, 2017, 120(5): 862-875.

[19] [19] LEE Y C, CHANG C H, LEE W J, et al. Altered chemokine profile in refractory mycoplasma pneumoniae pneumonia infected children ［J］. Journal of Microbiology, Immunology, and Infection, 2021, 54(4): 673-679.

[20] [20] TSUKANO K, SUZUKI K, SHIMAMORI T, et al. Profiles of serum amino acids to screen for catabolic and inflammation status in calves with mycoplasma bronchopneumonia ［J］. The Journal of Veterinary Medical Science, 2015, 77(1): 67-73.

[22] [22] LUO H, QIN G, WANG L, et al. Outcomes of infant cardiac surgery for congenital heart disease concomitant with persistent pneumonia: a retrospective cohort study ［J］. Journal of Cardiothoracic and Vascular Anesthesia, 2019, 33(2): 428-432.

[23] [23] PLEVKOVA J, HANACEK J, TATAR M. Cough and airway defence―special issue of respiratory physiology and neurobiology ［J］. Respiratory Physiology & Neurobiology, 2018, 257: 1-4.